Literature DB >> 21228761

Local health department costs associated with response to a school-based pertussis outbreak --- Omaha, Nebraska, September-November 2008.

.   

Abstract

Pertussis is a highly infectious, vaccine-preventable respiratory illness. With the advent of a vaccine, case numbers fell in the United States from a high of 265,269 in 1934 to a low of 1,010 cases in 1976, but then resurged to 25,827 in 2004. During 2004-2008, the average was 18,161 cases per year. Close contacts of persons with pertussis are at increased risk for developing infection and are recommended to receive preventive antibiotics for two reasons: 1) the illness can be debilitating, with cough lasting several weeks and sometimes being severe enough to cause urinary incontinence, rib fracture, or other complications; and 2) the illness can be fatal in infants; it caused an average of 17 deaths each year during 2002-2006. During pertussis outbreaks, the resources needed to identify and treat contacts can strain local public health resources. The Douglas County Health Department (DCHD) in Omaha, Nebraska, responded to a school-based pertussis outbreak with 26 cases occurring in late 2008. To assess the costs incurred by a local health department responding to such an outbreak, DCHD and CDC evaluated the total resources used by DCHD. This report describes the results of that analysis, which indicated that 1) staff members reported 1,032 person-hours spent responding to the outbreak, and 2) the total cost of outbreak response, including overhead, labor, travel, and other costs, was $52,131 (measured in 2008 U.S. dollars). The majority of costs (59%) occurred during an intensive 10-day period, when most of the contact tracing and prophylaxis recommendations were made. The elevated incidence of pertussis and the burden of response placed on health departments warrants exploring the impact of alternative response and chemoprophylaxis strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228761

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

Review 1.  The value of childhood combination vaccines: From beliefs to evidence.

Authors:  Khaled Maman; York Zöllner; Donato Greco; Gerard Duru; Semukaya Sendyona; Vanessa Remy
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Pertussis Vaccination Among Childcare Center Staff, Administrators, and Parents: Uptake, Policies, and Beliefs.

Authors:  Terri Rebmann; Travis M Loux; Daphne Lew; Mary Wakefield
Journal:  Matern Child Health J       Date:  2018-02

Review 3.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  Steps to a sustainable public health surveillance enterprise
a commentary from the international society for disease surveillance.

Authors:  Nabila Mirza; Tera Reynolds; Michael Coletta; Katie Suda; Ireneous Soyiri; Ariana Markle; Henry Leopold; Leslie Lenert; Erika Samoff; Alan Siniscalchi; Laura Streichert
Journal:  Online J Public Health Inform       Date:  2013-07-01

5.  The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010.

Authors:  Cristina Masseria; Girishanthy Krishnarajah
Journal:  BMC Infect Dis       Date:  2015-11-19       Impact factor: 3.090

6.  Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013.

Authors:  Josep Alvarez; Pere Godoy; Pedro Plans-Rubio; Neus Camps; Monica Carol; Gloria Carmona; Ruben Solano; Cristina Rius; Sofia Minguell; Irene Barrabeig; Maria R Sala-Farré; Raquel Rodriguez; Manuel Garcia-Cenoz; Carmen Muñoz-Almagro; Angela Dominguez
Journal:  Emerg Infect Dis       Date:  2020-11       Impact factor: 6.883

7.  Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children.

Authors:  Nicola Cotugno; Veronica Santilli; Giuseppe Rubens Pascucci; Emma Concetta Manno; Lesley De Armas; Suresh Pallikkuth; Annalisa Deodati; Donato Amodio; Paola Zangari; Sonia Zicari; Alessandra Ruggiero; Martina Fortin; Christina Bromley; Rajendra Pahwa; Paolo Rossi; Savita Pahwa; Paolo Palma
Journal:  Front Immunol       Date:  2020-10-05       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.